Download Citation
Article Source:
Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression
van der Wekken AJ,
Kuiper JL,
Saber A,
Terpstra MM,
Wei J,
et al.
(2017)
Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression.
PLOS ONE 12(8): e0182885.
https://doi.org/10.1371/journal.pone.0182885